The Effect and Potential Mechanism of Microbiota in Major Depressive Disorder

Authors

  • Yong Jiang

DOI:

https://doi.org/10.62051/qr5j3s93

Keywords:

Microbiota; Major Depressive Disorder; Intervention; Hypothalamus-Pituitary-Adrenal.

Abstract

Nowadays, Major depressive disorder is a global mental illness, for which antidepressant treatment with traditional drugs in the past is not effective. Gut microbiota (GM) plays a vital role in depression. The diversity of GM differs between patients inflicted with major depressive disorder and normal people. Besides, GM disorder is closely related to depression severity. This study found that anxiety as the clinical manifestation of major depressive disorder is highly intertwined with GM. There is a reasonable hypothesis about the influence of sleep disorder on patients with major depressive disorder. In addition, the GM system is considered to be related with depression. Meanwhile, this paper not only reviews the potential mechanism of gut-brain axis bidirectional action, but also investigates the existing relief measures and antidepressant interventions related to GM, and providing new insights for the depression pathogenesis and GM as adjuvant intervention therapy.

Downloads

Download data is not yet available.

References

Aizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., Ota, M., Koga, N., Hattori, K., & Kunugi, H. (2016). Possible association of Bifidobacterium and Lactobacillus in the GM of patients with major depressive disorder. J Affect Disord, 202, 254-257. https://doi.org/10.1016/j.jad.2016.05.038

Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016). Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition, 32(3), 315-320. https://doi.org/10.1016/j.nut.2015.09.003

Aziz, M. N. M., Kumar, J., Muhammad Nawawi, K. N., Raja Ali, R. A., & Mokhtar, N. M. (2021). Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients, 13(9). https://doi.org/10.3390/nu13093061

Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., Moore, T. A., Russell, G., & Surawicz, C. (2011). Treating clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol, 9(12), 1044-1049. https://doi.org/10.1016/j.cgh.2011.08.014

Bennabi, D., Aouizerate, B., El-Hage, W., Doumy, O., Moliere, F., Courtet, P., Nieto, I., Bellivier, F., Bubrovsky, M., Vaiva, G., Holztmann, J., Bougerol, T., Richieri, R., Lancon, C., Camus, V., Saba, G., Haesbaert, F., d'Amato, T., Charpeaud, T., . . . Haffen, E. (2015). Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord, 171, 137-141. https://doi.org/10.1016/j.jad.2014.09.020

Boku, S., Nakagawa, S., Toda, H., & Hishimoto, A. (2018). Neural basis of major depressive disorder: Beyond monoamine hypothesis. Psychiatry Clin Neurosci, 72(1), 3-12. https://doi.org/10.1111/pcn.12604

Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., Gulyás, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B. T., Diamond, B., & Pettersson, S. (2014). The GM influences blood-brain barrier permeability in mice. Sci Transl Med, 6(263), 263ra158. https://doi.org/10.1126/scitranslmed.3009759

Brown, A. S., & Gershon, S. (1993). Dopamine and depression. J Neural Transm Gen Sect, 91(2-3), 75-109. https://doi.org/10.1007/bf01245227

Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. P., & Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry, 38(1), 15-22. https://doi.org/10.1001/archpsyc.1981.01780260017001

Cheung, S. G., Goldenthal, A. R., Uhlemann, A. C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019). Systematic Review of GM and Major Depression. Front Psychiatry, 10, 34. https://doi.org/10.3389/fpsyt.2019.00034

Daneman, R., & Prat, A. (2015). The Blood–Brain Barrier. Cold Spring Harbor Perspectives in Biology, 7(1), 32-34.

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 9(1), 46-56. https://doi.org/10.1038/nrn2297

Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011). Normal GM modulates brain development and behavior. Proc Natl Acad Sci U S A, 108(7), 3047-3052. https://doi.org/10.1073/pnas.1010529108

Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science, 308(5728), 1635-1638. https://doi.org/10.1126/science.1110591

Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016). Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism, 7, 49. https://doi.org/10.1186/s13229-016-0110-z

Fond, G. B., Lagier, J. C., Honore, S., Lancon, C., Korchia, T., Sunhary De Verville, P. L., Llorca, P. M., Auquier, P., Guedj, E., & Boyer, L. (2020). Microbiota-Orientated Treatments for Major Depression and Schizophrenia. Nutrients, 12(4). https://doi.org/10.3390/nu12041024

Geng, S., Cheng, S., Li, Y., Wen, Z., Ma, X., Jiang, X., Wang, Y., & Han, X. (2018). Faecal Microbiota Transplantation Reduces Susceptibility to Epithelial Injury and Modulates Tryptophan Metabolism of the Microbial Community in a Piglet Model. J Crohns Colitis, 12(11), 1359-1374. https://doi.org/10.1093/ecco-jcc/jjy103

Goh, K. K., Liu, Y. W., Kuo, P. H., Chung, Y. E., Lu, M. L., & Chen, C. H. (2019). Effect of probiotics on depressive symptoms: A meta-analysis of human studies. Psychiatry Res, 282, 112568. https://doi.org/10.1016/j.psychres.2019.112568

Green, C., Stolicyn, A., Harris, M. A., Shen, X., Romaniuk, L., Barbu, M. C., Hawkins, E. L., Wardlaw, J. M., Steele, J. D., Waiter, G. D., Sandu, A. L., Campbell, A., Porteous, D. J., Seckl, J. R., Lawrie, S. M., Reynolds, R. M., Cavanagh, J., McIntosh, A. M., & Whalley, H. C. (2021). Hair glucocorticoids are associated with childhood adversity, depressive symptoms and reduced global and lobar grey matter in Generation Scotland. Transl Psychiatry, 11(1), 523. https://doi.org/10.1038/s41398-021-01644-9

Hai-Yin, J., Xue, Z., Zheng-He, Y., Zhe, Z., Min, D., Jian-Hua, Z., & Bing, R. (2018). Altered GM profile in patients with generalized anxiety disorder. Journal of Psychiatric Research, 104, 130-136.

Heuser, I., Yassouridis, A., & Holsboer, F. (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res, 28(4), 341-356. https://doi.org/10.1016/0022-3956(94)90017-5

Hirschfeld, R. M. (2000). History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry, 61 Suppl 6, 4-6.

Ho, Y. T., Tsai, Y. C., Kuo, T. B. J., & Yang, C. C. H. (2021). Effects of Lactobacillus plantarum PS128 on Depressive Symptoms and Sleep Quality in Self-Reported Insomniacs: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial. Nutrients, 13(8). https://doi.org/10.3390/nu13082820

Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z. Y., Roybon, L., Melki, R., & Li, J. Y. (2014). Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol, 128(6), 805-820. https://doi.org/10.1007/s00401-014-1343-6

Jembrek, M. J., & Vlainic, J. (2015). GABA Receptors: Pharmacological Potential and Pitfalls. Curr Pharm Des, 21(34), 4943-4959. https://doi.org/10.2174/1381612821666150914121624

Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., & Shi, J. (2019). altered fecal microbiota composition in patients with major depressive 4 disorder 5 6 7.

Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., & Ruan, B. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun, 48, 186-194. https://doi.org/10.1016/j.bbi.2015.03.016

Kang, D. W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., Pollard, E. L., Roux, S., Sadowsky, M. J., Lipson, K. S., Sullivan, M. B., Caporaso, J. G., & Krajmalnik-Brown, R. (2017). Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome, 5(1), 10. https://doi.org/10.1186/s40168-016-0225-7

Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019). Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr, 38(2), 522-528. https://doi.org/10.1016/j.clnu.2018.04.010

Kelly, J. R., Borre, Y., C, O. B., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P., Stanton, C., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016). Transferring the blues: Depression-associated GM induces neurobehavioural changes in the rat. J Psychiatr Res, 82, 109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019

Kiecolt-Glaser, J. K., Wilson, S. J., Bailey, M. L., Andridge, R., Peng, J., Jaremka, L. M., Fagundes, C. P., Malarkey, W. B., Laskowski, B., & Belury, M. A. (2018). Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation. Psychoneuroendocrinology, 98, 52-60. https://doi.org/10.1016/j.psyneuen.2018.08.007

Konturek, S. J., Konturek, J. W., Pawlik, T., & Brzozowski, T. (2004). Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol, 55(1 Pt 2), 137-154.

Li, N., Wang, Q., Wang, Y., Sun, A., Lin, Y., Jin, Y., & Li, X. (2019). Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the GM-inflammation-brain axis. Stress, 22(5), 592-602. https://doi.org/10.1080/10253890.2019.1617267

Lin, P., Ding, B., Feng, C., Yin, S., Zhang, T., Qi, X., Lv, H., Guo, X., Dong, K., Zhu, Y., & Li, Q. (2017). Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord, 207, 300-304. https://doi.org/10.1016/j.jad.2016.09.051

Liu, Y., Zhang, S., Li, X., Liu, E., Wang, X., Zhou, Q., Ye, J., & Wang, J. Z. (2020). Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier. Biosci Rep, 40(2). https://doi.org/10.1042/bsr20193629

Mason, B. L., Li, Q., Minhajuddin, A., Czysz, A. H., Coughlin, L. A., Hussain, S. K., Koh, A. Y., & Trivedi, M. H. (2020). Reduced anti-inflammatory GM are associated with depression and anhedonia. J Affect Disord, 266, 394-401. https://doi.org/10.1016/j.jad.2020.01.137

Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., & Rudi, K. (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil, 26(8), 1155-1162. https://doi.org/10.1111/nmo.12378

Ng, Q. X., Peters, C., Ho, C. Y. X., Yutong, D. L., & Yeo, W. S. (2017). A meta-analysis of the use of probiotics to alleviate depressive symptoms. Journal of Affective Disorders, 13.

Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013). Development, maintenance and disruption of the blood-brain barrier. Nat Med, 19(12), 1584-1596. https://doi.org/10.1038/nm.3407

Ogawa, Y., Miyoshi, C., Obana, N., Yajima, K., Hotta-Hirashima, N., Ikkyu, A., Kanno, S., Soga, T., Fukuda, S., & Yanagisawa, M. (2020). GM depletion by chronic antibiotic treatment alters the sleep/wake architecture and sleep EEG power spectra in mice. Sci Rep, 10(1), 19554. https://doi.org/10.1038/s41598-020-76562-9

Otaka, M., Kikuchi-Hayakawa, H., Ogura, J., Ishikawa, H., Yomogida, Y., Ota, M., Hidese, S., Ishida, I., Aida, M., Matsuda, K., Kawai, M., Yoshida, S., & Kunugi, H. (2021). Effect of Lacticaseibacillus paracasei Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in GM. Microorganisms, 9(5). https://doi.org/10.3390/microorganisms9051026

Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016). Major depressive disorder. Nat Rev Dis Primers, 2, 16065. https://doi.org/10.1038/nrdp.2016.65

Öztürk, M., Yalın Sapmaz, Ş., Kandemir, H., Taneli, F., & Aydemir, Ö. (2021). The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder. Int J Clin Pract, 75(4), e13739. https://doi.org/10.1111/ijcp.13739

Pariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., & Miller, A. H. (1999). The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology, 140(9), 4359-4366. https://doi.org/10.1210/endo.140.9.6986

Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F. P., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., De Palma, G., Pigrau, M., Ford, A. C., Macri, J., Berger, B., Bergonzelli, G., Surette, M. G., . . . Bercik, P. (2017). Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology, 153(2), 448-459.e448. https://doi.org/10.1053/j.gastro.2017.05.003

Rao, J., Qiao, Y., Xie, R., Lin, L., Jiang, J., Wang, C., & Li, G. (2021). Fecal microbiota transplantation ameliorates stress-induced depression-like behaviors associated with the inhibition of glial and NLRP3 inflammasome in rat brain. J Psychiatr Res, 137, 147-157. https://doi.org/10.1016/j.jpsychires.2021.02.057

Rochfort, K. D., Collins, L. E., Murphy, R. P., & Cummins, P. M. (2014). Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One, 9(7), e101815. https://doi.org/10.1371/journal.pone.0101815

Ryan, K. M., Allers, K. A., McLoughlin, D. M., & Harkin, A. (2020). Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy. Brain Behav Immun, 83, 153-162. https://doi.org/10.1016/j.bbi.2019.10.005

Schaub, A. C., Schneider, E., Vazquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., Borgwardt, S., Raes, J., Schmidt, A., & Lang, U. E. (2022). Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry, 12(1), 227. https://doi.org/10.1038/s41398-022-01977-z

Spiegelhalder, K., Regen, W., Nanovska, S., Baglioni, C., & Riemann, D. (2013). Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. Curr Psychiatry Rep, 15(6), 364. https://doi.org/10.1007/s11920-013-0364-5

Takada, M., Nishida, K., Gondo, Y., Kikuchi-Hayakawa, H., Ishikawa, H., Suda, K., Kawai, M., Hoshi, R., Kuwano, Y., Miyazaki, K., & Rokutan, K. (2017). Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Benef Microbes, 8(2), 153-162. https://doi.org/10.3920/bm2016.0150

Takada, M., Nishida, K., Kataoka-Kato, A., Gondo, Y., Ishikawa, H., Suda, K., Kawai, M., Hoshi, R., Watanabe, O., Igarashi, T., Kuwano, Y., Miyazaki, K., & Rokutan, K. (2016). Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil, 28(7), 1027-1036. https://doi.org/10.1111/nmo.12804

Tang, R., & Li, L. (2021). Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus. Can J Infect Dis Med Microbiol, 2021, 6632266. https://doi.org/10.1155/2021/6632266

Wang, W., Lv, S., Zhou, Y., Fu, J., Li, C., & Liu, P. (2011). Tumor necrosis factor-α affects blood-brain barrier permeability in acetaminophen-induced acute liver failure. Eur J Gastroenterol Hepatol, 23(7), 552-558. https://doi.org/10.1097/MEG.0b013e3283470212

Weng, L., Dong, S., Wang, S., Yi, L., & Geng, D. (2019). Macranthol attenuates lipopolysaccharide-induced depressive-like behaviors by inhibiting neuroinflammation in prefrontal cortex. Physiol Behav, 204, 33-40. https://doi.org/10.1016/j.physbeh.2019.02.010

Wróbel, A., Serefko, A., Rechberger, E., Banczerowska-Górska, M., Poleszak, E., Dudka, J., Skorupska, K., Miotła, P., Semczuk, A., Kulik-Rechberger, B., Mandziuk, S., & Rechberger, T. (2018). Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats. Eur J Pharmacol, 837, 127-136. https://doi.org/10.1016/j.ejphar.2018.08.027

Wu, Q., Xu, Z., Song, S., Zhang, H., Zhang, W., Liu, L., Chen, Y., & Sun, J. (2020). GM modulates stress-induced hypertension through the HPA axis. Brain Res Bull, 162, 49-58. https://doi.org/10.1016/j.brainresbull.2020.05.014

Wu, W. L., Adame, M. D., Liou, C. W., Barlow, J. T., Lai, T. T., Sharon, G., Schretter, C. E., Needham, B. D., Wang, M. I., Tang, W., Ousey, J., Lin, Y. Y., Yao, T. H., Abdel-Haq, R., Beadle, K., Gradinaru, V., Ismagilov, R. F., & Mazmanian, S. K. (2021). Microbiota regulate social behaviour via stress response neurons in the brain. Nature, 595(7867), 409-414. https://doi.org/10.1038/s41586-021-03669-y

Wu, Y., Li, S., Hu, K., & Yang, J. (2021). Evidence of the moderating role of hair cortisol and hair cortisone in the relationship between work stress and depression symptoms among Chinese fishermen. J Affect Disord, 294, 868-875. https://doi.org/10.1016/j.jad.2021.06.023

Yan, Z. X., Gao, X. J., Li, T., Wei, B., Wang, P. P., Yang, Y., & Yan, R. (2018). Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming. Appl Environ Microbiol, 84(14). https://doi.org/10.1128/aem.00434-18

Zhai, L., Zhang, H., & Zhang, D. (2015). SLEEP DURATION AND DEPRESSION AMONG ADULTS: A META-ANALYSIS OF PROSPECTIVE STUDIES. Depress Anxiety, 32(9), 664-670. https://doi.org/10.1002/da.22386

Zhao, W., Hu, Y., Li, C., Li, N., Zhu, S., Tan, X., Li, M., Zhang, Y., Xu, Z., Ding, Z., Hu, L., Liu, Z., & Sun, J. (2020). Transplantation of fecal microbiota from patients with alcoholism induces anxiety/depression behaviors and decreases brain mGluR1/PKC ε levels in mouse. Biofactors, 46(1), 38-54. https://doi.org/10.1002/biof.1567

Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., Zhang, X., Yang, D., Yang, Y., Meng, H., Li, W., Melgiri, N. D., Licinio, J., Wei, H., & Xie, P. (2016). Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry, 21(6), 786-796. https://doi.org/10.1038/mp.2016.44

Zhu, F., Tu, H., & Chen, T. (2022). The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect. Nutrients, 14(10), 2081. https://www.mdpi.com/2072-6643/14/10/2081

Downloads

Published

13-11-2023

How to Cite

Jiang, Y. (2023). The Effect and Potential Mechanism of Microbiota in Major Depressive Disorder. Transactions on Materials, Biotechnology and Life Sciences, 1, 20-27. https://doi.org/10.62051/qr5j3s93